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Abstract 
BACKGROUND: Hantavirus infection is manifested as an urgent, severe and life-threatening disease caused by 
Hantavirus. The virus affects human endothelial cells. The natural reservoir of the Hantaviruses is chronically 
infected rodents. Human infection is accidental. Occurs by intake of contaminated food or inhalation of 
contaminated secretion from infected rodents' excretions have an increased risk of contamination. The most 
affected persons are people who work in nature. The virus causes haemorrhages, fever and acute renal failure. 
The disease appears more frequently in endemic regions with the lethality of 6-15%. The disease can surprise 
doctors with severity, urgency and undefined clinical picture. Fast clinical evaluation, proper and urgent diagnosis 
and treatment can improve the safe life of these patients.  
CASE REPORT: We report a case of 45 -year-old male patient worked as a shepherd on mountain Babuna near 
the city of Veles in the Republic of Macedonia at the end of the summer in the year 2017, presented with 
prolonged hemorrhagic fever with renal syndrome. The clinical presentation and lab findings support the diagnosis 
of Hantavirus infection with acute renal failure.  
CONCLUSION: It is necessary to raise the awareness of the family doctors for the hantavirus disease, especially 
in countries with sporadic cases, as in our country. It needs for prompt and timely diagnosis, timely hospitalisation 
and initiation of therapy. 
 
 
 
 
Introduction 
 
Hantavirus infections (order Bunyavirales, 
family Hantaviridae) attract more attention in the 
world. For the first time were reported entities in 
Korean wore, beside river Hantan. Three thousand 
soldiers were faced with febrile fever, acute renal 
failure, shook, with the lethality of 7%. The cause of 
the disease is Hantavirus – single strain RNA virus 
with 21species and more than 30 genotypes. 
Hantavirus affects human endothelial cells and 
causes vascular instability [1], [2]. The natural 
reservoir of the Hantaviruses is chronically infected 
rodent. Virus and the host have a long period of co-
evaluation without the existing disease [3]. Infection is 
accidental. Infection occurs by ingestion of 
contaminated food with excretions (urine, faeces and 
sputum) or inhalation of contaminated dust from an 
infected rodent. People (shepherds, foresters, woods) 
with close contact with rodents’ excretions have an 
increased risk of contamination. The most common 
types of Hantaviruses in Asia are Amur and Seoul 
virus with the lethality of 17%. Seoul Hantavirus 
(SEOV) causes mild to moderate hemorrhagic fever 
with renal failure in Russia, South Korea and China. 
Few tens to a few thousand, human infections were 
diagnosed in China and four sporadic human cases in 
the United Kingdom, France Netherlands [4] and 
Germany [5], [6]. Dobrava, Tula, Puumala and 
Saaremaa viruses are most frequent with the most 
severe clinical pictures on Balkan [7]. In our region, 
the most frequent is Dobrava Hantavirus. The 
infection from human to human is very rare, with the 
exception of Ande virus in South Argentina. Puumala 
virus stands as the main contributor to hemorrhagic 
fever with renal syndrome (HFRS) in Europe, while 
the Dobrava virus is the causative agent of the most 
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severe HFRS causes in central Europe. The mortality 
rate for Dobrava viruses is more than 10% [8]. Bruges 
virus is a novel hantavirus found harboured by the 
European mole (Talpa europea) which is the host of 
Nova virus. These findings highlight the complexity of 
hantavirus evolution and the importance of further 
investigation of hantavirus reservoir relationship [3]. 
There are three types of the disease with different 
clinical manifestations, but often some of the 
symptoms are found in the three types of disease, 
especially in the first two types: 1. NE (nephritic 
enteropathy), 2. HFRS (hemorrhathe gic the fever with 
renal syndrome), and 3. HPS (Hemorrhagic 
pulmonary syndrome). HFRS last from 7-36 days with 
the lethality of 6-15% and is the most frequent [9]. The 
Hantavirus causes systematic damages of capillaries 
and venules. It induces hemorrhagic manifestation 
and vascular disturbances, which causes acute renal 
failure as a result of interstitial haemorrhages and 
infiltrates [2]. The clinical expression of the disease is 
classified in 5 phases: febricity, hypotension, oliguria, 
diuresis and convalescence [10]. The first phase is 
characterised by the predominance of fever. The first 
3 to 4 days are characterised by the appearance of 
the chest and abdominal pain, fever, myalgia, 
photophobia, malaise, diarrhoea, vomiting, diffuse 
redness on the face. Symptoms in this period are very 
non-specific and can be difficult to differentiate from a 
simple virus infection accompanied by diarrhea. In the 
fourth and fifth day of illness, appear diffuse petechial 
hemorrhages, enanthema on the hard palate, 
hemorrhages in conjunctives, involvement of the 
temporal visual field, coughing, hematuria and 
proteinuria. 
The second phase is characterised with 
predomination of hypotension: The hypotension is 
developed in the 3-6 days of disease with strong 
expressed malaise, shook, leukocytosis and 
thrombocytopenia, with a wide range of renal 
impairment – (acute tubulointerstitial nephritis) or 
(necrotising glomerulonephritis, and IgA nephropathy). 
The severity of thrombocytopenia in a patient with 
HFRS may predict disease severity and critical 
patients
’
 survival [11]. This phase is also nonspecific 
and difficult to recognise and reminiscent of 
dehydration, caused by prolonged fever and 
diarrhoea. The third phase is with the appearance of 
oliguria: In that phase, if it is not done on time a 
complete blood account analysis which is 
characterised with thrombocytopenia and increased 
values of blood creatinine, it is not possible to 
recognise the disease. If the disease is not recognized 
at this stage of the disease, the likelihood of a fatal 
event is possible due to advanced acute renal failure. 
The eighth day of the disease is also characterised by 
hemorrhagic manifestations. 
The fourth phase is characterised by diuresis. 
If the patient survived, an intensified diuresis occurs 
on the eleventh day of the illness. 
The fifth phase is convalescence, which lasts 
2 weeks to 6 months. All five phases are not strictly 
delineated. Sequels are rare with chronic renal failure 
and hypotension. Extrarenal symptoms in this disease 
are presents as acute myopia, convulsions, 
myocarditis, gastrointestinal bleeding, liver, pancreas, 
thyroid gland and pulmonary damages.  
The diagnosis is established based on the 
clinical picture and laboratory investigations. The main 
factor on which depends on the severity of the 
disease is the degree of endothelial permeability and 
genetic predisposition, HLA-B8, DRB1*0301, C4A*Q0, 
or DQ2 alleles, HLA B35. Thrombocytopenia appears 
at the early stage of the disease. Detection of specific 
IgM antibodies confirms the diagnosis [12]. Increased 
levels of procalcitonin could be predictive of disease 
severity, secondary bacterial infection and mortality in 
patients with HFRS caused by Hantavirus infection 
[13]. There is no applicative etiological therapy. 
Supportive therapy, such hemodialysis, correction of 
bleeding and platelets cells, blood pressure, antibiotic 
treatment of bacterial infection, anticoagulant therapy 
and supervision. Ribavirin and interferon have limited 
results. Prevention is particularly important. It is 
recommended to avoid places with an increased 
presence of mice or other rodents to reducing contact 
with contaminated excretions. Preventive measures in 
the houses and the environment by eliminating the 
food sources are useful. These measures could make 
home and workspaces unattractive to rodents [14]. 
There are needs of increased efforts for preparing 
effective and reliable vaccine with recombinant RNA 
technology. The potential effect of the inactivated 
Hantavirus vaccine remains controversial. It appears 
in the research in the Republic of Korea; the vaccine 
is moderately effective for patients (older patients) at 
high risk for HFRS [15] Current vaccines are 
ineffective, with development of neutralising 
antibodies [16]. Until today there is no suitable 
vaccine with inactivated Hantaviruses that will provide 
adequate protection in humans. 
 
 
Case Report - Our Experience with 
Hantavirus Infected Patient - 
(Hemorrhagic Fever and Renal Syndrome) 
 
The present article reports a case of 45 old 
male patients, presented with Hantavirus infection 
disease. He worked as a shepherd on the Babuna 
Mountain near Veles in the Republic of Macedonia. 
History is negative for any disease of interest. 
Epidemiological history is positive, and it is connected 
with eating contaminated watermelon. He visited his 
family doctor after 6 days of the onset of symptoms. 
The first symptoms were high temperature, > 38.5°C, 
which lasted 5-6 days, prolonged vomiting, diarrhoea 
for 5-6 days, dorsal, strong lumbar and sacral pain, 
abdominal pain, myalgia, pronounced fatigue, reduced 
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coordination, and cough. The patient's entire condition 
was unspecific and reminded of gastrointestinal 
infection and the common cold. By first physical 
examination in the family doctor's office was found the 
existence of elevated temperature > 39°C, 
bradycardia, diffuse redness of the face, photophobia, 
hypotension, petechial haemorrhages of hard palate 
and conjunctiva and temporally disturbed vision, 
reduced coordination, slow speech, hoarse voice and 
cough. Lab analyses were performed in the first visit 
of the patient. The measured blood pressure was 
100/70 mmHg.  
Table1: Laboratory results of the first and second day of 
ambulatory examinations  
 Hb Er Le Gr HCT PLT Glycemi
a 
Urea Cratini
ne 
ALT AST 
First 
day 
195 g 7.15 11.44x1
0
9
/L
 
83.8 69 45 6.9 11.8 159 43.5 68 
Secon
d day 
195 7.26 19x10
9
/L 85.3 70 45 8.1 17.4 374 44.5 69 
Ref. 
value
s 
120-
174gr/l 
4.00-
5.50x10
1
2
/l
 
5.00-
10.00x1
0
9
/ l
 
40-
70% 
36-
52% 
150-
400x10
9
/l 
4.2-6.5 
mmol/l 
1.7-8.5 
mmol/l 
56-120 
µmol/l 
< 45 
U/l 
< 45U/l 
 
The Laboratory results of the first ambulatory 
day are presented in Table 1. Blood analysis showed 
high values of haemoglobin, erythrocytes and 
hematocrit (haemoconcentration), increased number 
of white blood cells, low platelet counts, increased 
values of blood sugar, creatinine, urea and alanine 
transaminase (ALT), aspartate transaminase (AST) 
values. Urine analysis showed mild proteinuria and 
hematuria. We suggested urgent hospitalisation 
because of the complexity of the symptoms, high 
fever and signs of renal failure. He rejected to be 
hospitalised, but finally, he decided to visit as with his 
wife the next day. We started intravenous rehydration 
and symptomatic treatment.  
During the review of the patient's condition, 
the deterioration of the health status was observed, 
with frequent vomiting, hypotension, oedema on the 
face, vision disorder, pronounced malaise, enanthema 
of the soft palate, conjunctivas bleeding and 
appearance of the oliguria. The measured blood 
pressure was 90/60 mmHg. The second-day lab 
analyses were done. Prompt worsening, with the 
persistence of thrombocytopenia, 
haemoconcentration, hyperglycemia, uremia, high 
levels of creatinine values, liver and pancreas 
damages were observed. 
The patient was immediately referred to the 
General Hospital, Department of Internal Medicine in 
Veles, for further hospital treatment. Laboratory 
analyses, chest and abdominal x-ray were performed. 
An abdominal x-ray was normal, without signs of 
acute surgical disease. The chest x-ray was normal. 
Because of the appearance of strong abdominal pain, 
vomiting of bloody content and unclear clinical picture 
of the disease was made unsuccessful gastroscopy 
attempt in the local hospital. Shortly after that, 
complete anuria appeared (creatinine value 541 
µmol/l, thrombocytes 29 x 10
9
/l, leucocytes 22.5 x 10) 
and the patient was forwarded as an emergency 
patient to the University Clinic for Nephrology (UCN) 
Skopje where were done lab analysis and serological 
analysis. Serological analyses (ELISA) done at the 
Laboratory for Virology and molecular diagnostics, 
Institute of Public Health, showed the existence of IgM 
antibodies against Hantavirus. 
The serological analysis was not performed 
again. After establishing the diagnosis and started 
hemodialysis patient was transferred at University 
Clinic for Infectious disease and febrile conditions 
(UCIDFC) Skopje. Consultation with Transfusion 
department was done twice times, where was 
analysed coagulation. 
Table 2: The results of the blood coagulation analyses 
Transfusion 
department 
First analysis Second analysis-after 
2 days 
Reference values 
Number of platelets  33 96 150-450x10
9
/l 
Hematocrit 43.2% 20.5% 35-50% 
Prothrombin time 11.3 12.32 9-14.2 sec. 
Activated partial 
thromboplastin time 
39.59 45.01 27.9-37.7% 
Thrombin time 24.64 21.73 16.1-24.1 sec. 
D-dimer 4306.42 2553.13 0-500 ng/ml 
 
The first analysis showed consumptive 
thrombocytopenia with activation of secondary 
thrombolysis and hemolytic anaemia. The second 
analysis was done after started anticoagulation 
treatment. Hemodialysis was performed three times at 
UCN. The patient was hospitalised 21 days at 
UCIDFC, and he had important improvement of the 
general condition and renal function. Lab results 
during hospitalisation are presented in Table 3. 
Table 3: Lab analyses performed at UCIDFC 
Days of the 
hospital 
treatment 
4-th day 6-th 
day 
8-th 
day 
11-day 14-th 
day 
17-th day 20-day 21-th Reference values 
Hb  128 76 103 100 93 96 103 106 120-174 g/l 
Er  4.1 2.5 3.4 3.2 3.1 3.2 3.4 3.5 4.00-.50.50x10
12
/l 
Le 25.8 20.2 19.5 15.0 10.4 5.3 7.9 8.2 5.00-10.00x10
9
/l 
PLT 46 100 90 119 150 129 99 303 150-450x10
9
/l 
Hematocrit 36 22 31 30 29 31 33 33 35-50% 
Gr 74 65 77 76 69 52 58 49 40-70% 
Glycemia 6.7  5.7 5.7 6.3 5.6 5.3 3.5 4.2-6.5 mmol/l 
Urea 26 36.7 18.8 17.9 14.1 6.3 5.3 3.5 1.7-8.5 mmol/l 
Creatinine  604 630 563 364 340 128 89 87 56-120 µg/l 
ALT  27  80  95    <45 U/l 
AST  35  64  69    <45 U/l 
LDH 944 984 1157  958    225-450 U/l 
CK 162 190 31  51    24-190 U/l 
K 3.5 3.7 3.8 3.6 3.9 4.3  4.9 3.6-5.5 mmol/l 
Na mmol/L 125 125 133 135 144 145  143 135-155 mmol/l 
Ca mmol/L 1.71 2.3 1.98 1.92 1.95 2.17  2.39 2.02-2.60 mmol/l 
ABS-pH 7.41 7.47 7.43       
Albumins   26  27    38-51 g/l 
Globulins    28  31    26-46 g/l 
Total 
proteins 
  54  58    66-87 g/l 
urine      20-25Er,6-
8 Le, the 
mass of 
bacteria 
 10-
15Le 
6-8Er 
 
CRP 25  33  34 19    
agriculture       Klebsiell
a 
pn.esbl+ 
  
Serology for Hantavirus IgM Antibodies positive  
 
The results are connected with the severity of 
clinical pictures. He received supportive therapy. 
Correction of bleeding and platelet was done with 
blood transfusions and blood products on several 
occasions. Rehydration with intravenous infusions, 
anticoagulant therapy, antibiotics treatment, 
hemodialysis and supervision was done. The 
complete patient's treatment provided complete 
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recovery without sequels. Control examinations were 
performed regularly.  
Phylogenetic analysis of the Hantavirus was 
performed at the Medical School Aristotle University of 
Thessaloniki, conforming Dobrava serotype.  
Established Diagnosis: Hemorrhagic fever 
with Renal Syndrome, Hantavirus infection (Dobrava 
serotype). 
 
 
Discussion  
 
Hantavirus infections with HFRS are 
periodically seen in our country at the end of the 
summer and autumn among persons who are working 
in nature. The diagnosis and treatment can be difficult, 
especially in the region where the disease is not 
frequent, and the doctors are not familiar with that 
disease. Hantavirus infections are more frequent in 
Korea and China. The minor peak season is from May 
to July, and the major peak is in the harvest season, 
from October to December when the ground is 
disturbed, and there was a lot of dust [17]. The 
disease has a high percentage of mortality. The 
mountain Babuna and region around cities Tetovo and 
Gostivar are endemic regions for Hantavirus infection, 
but the disease appears periodically. According to 
data of the Institute of Public Health in 2017, 17 
patients with detected Hantavirus infection were 
reported, and calculation of fatality rate for this 
disease is 11.8%. In the 2018 year, 9 cases of 
Hantavirus infection were reported. Dobrava serotype 
was confirmed for the cases in 2017. Two patients 
died, and 3 patients had chronic kidneys failure. Due 
to the need for treatment and prevention of the 
disease, many studies have been undertaken, 
including the efforts on creating a new, more effective 
vaccine [18]. Despite the emergence of this disease, 
there is a space for improvement concerning making a 
rapid and accurate diagnosis and implementing 
appropriate care. The family doctors and clinicians are 
facing challenges in dialling with the unfamiliar 
disease in people who are working in nature. 
Hantavirus infection with HFRS is a very urgent 
disease with very prompt developing of the spectrum 
of unspecific symptoms which can make difficulties in 
establishing of the diagnosis, especially in regions 
where the disease is not very frequent, and it can 
cause delayed of the treatment. Every delayed of the 
treatment can be the reason for fatal consequences 
and sequels. Making algorithm is not possible 
because the disease is not very frequent, and clinical 
presentation is not specific. 
The goals of the treatments are quick 
recognition, lab investigations, prompt symptomatic 
treatment, and hemodialysis in patients with anuria or 
oliguria. Hantavirus disease should be considered in 
the differential diagnosis of leptospirosis and 
rickettsiosis, unspecific gastroenterocolitis, severe 
atypical pneumonia, pneumonia influence, heart 
failure, etc. Accurate diagnosis and timely initiation of 
the therapy are critical to the management. The main 
diagnostic method is the serological analysis of 
elevated Ig-M antibodies for Hantavirus [12]. Risk 
factors for Hantavirus infection are winter 
temperature, population density and enough available 
food for rodent [19]. Preventive and education 
measures are crucial. Many attempts have been 
made to produce a vaccine for Hantaviruses for 
different types, but most often it is unsuccessful. 
In conclusion, Hantavirus disease has an 
unclear and profuse clinical picture with different and 
variable symptoms in people who work in nature. The 
symptoms are prolonged febricity, lumbosacral pain, 
abdominal pain, vomiting, malaise, dehydration and 
signs of acute renal failure, thrombocytopenia, and 
often looks like a simple cold and gastrointestinal virus 
infection. It is necessary to raise the awareness of the 
family doctors for this disease, especially in countries 
with sporadic cases, as in our country. It needs for 
prompt and timely diagnosis, timely hospitalisation 
and initiation of therapy. There is not etiological 
therapy, but symptomatic treatment can safe a life. 
Using preventive measures and education can reduce 
the risk of infection. Eradication of environment of 
rodents’ excretions is useful in the situation of lack of 
proper vaccines. 
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